Boarfish (Capros aper) is an underutilised pelagic fish species found in abundance in Irish waters (1) . Boarfish is a potential source of unique uncharacterised proteins. Research previously undertaken has shown a favourable effect of fish derived protein hydrolysate consumption on glycaemic control in diabetic murine models (2) . This study aims to investigate the effect of daily boarfish protein hydrolysate (BFH) consumption on glycated haemoglobin and body mass index (BMI) in overweight human participants.
. Boarfish is a potential source of unique uncharacterised proteins. Research previously undertaken has shown a favourable effect of fish derived protein hydrolysate consumption on glycaemic control in diabetic murine models (2) . This study aims to investigate the effect of daily boarfish protein hydrolysate (BFH) consumption on glycated haemoglobin and body mass index (BMI) in overweight human participants.
A randomised parallel placebo-controlled human intervention study was undertaken to investigate the effect of consuming BFH for 12 weeks. Participants (n = 40) that met the following inclusion criteria were recruited; aged between 18-65 years, non-smoker, not currently pregnant or lactating, BMI > 25·0 kg/m 2 and, free from chronic illness. Participants were randomly assigned to consume either 3·5 g/day of BFH or 3·5 g of cellulose. Measures taken at baseline and post-intervention (week 12) include: height and weight, fasting glycated haemoglobin, glucose, insulin, leptin, glucagon like peptide (GLP-1), adiponectin and lipid profile. Analysis of covariance (ANCOVA) controlling for baseline values as well as other covariates (age & BMI), was used to compare differences between groups over time.
Compliance was reported as 95%. The BFH had no significant effect on any of the markers when compared with control. Although an equivalent dose of BFH demonstrated anti-diabetic properties in murine models, the same effects were not observed in humans and a larger dose may be required. 
BMI; body mass index, HDL; high density lipoprotein, LDL; low density lipoprotein, SD; standard deviation, TP; timepoint. P values are generated using ANCOVA assessing the mean difference between TP2 variables of the control group, and TP2 variables of the treatment group, with TP1 variables as the covariate.
